Pathogenic mutations in genes like APP, PSEN1, and PSEN2 are found in approximately 15–20%, 70–80, and 5% of patients with familial AD, respectively (Ryan and Rossor, 2010; Williams, 2011). This evidence concerns the gene PSEN1 and Alzheimer disease.